Pages that link to "Q33763351"
Jump to navigation
Jump to search
The following pages link to Progressive multifocal leukoencephalopathy and other forms of JC virus disease (Q33763351):
Displaying 50 items.
- Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain (Q24619923) (← links)
- Progressive multifocal leukoencephalopathy: current treatment options and future perspectives (Q26776236) (← links)
- Emerging Roles of Viroporins Encoded by DNA Viruses: Novel Targets for Antivirals? (Q26778969) (← links)
- Migration and pathogenicity of CD8 T cells in central nervous system diseases (Q26784139) (← links)
- New insights on human polyomavirus JC and pathogenesis of progressive multifocal leukoencephalopathy (Q26822247) (← links)
- JC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes? (Q26852060) (← links)
- Progressive multifocal leukoencephalopathy: clinical and molecular aspects (Q26858968) (← links)
- Novel approaches and challenges to treatment of central nervous system viral infections (Q26862449) (← links)
- Progressive Multifocal Leukoencephalopathy-Associated Mutations in the JC Polyomavirus Capsid Disrupt Lactoseries Tetrasaccharide c Binding (Q27678593) (← links)
- Insights into the initiation of JC virus DNA replication derived from the crystal structure of the T-antigen origin binding domain (Q27681947) (← links)
- Virucidal nanofiber textiles based on photosensitized production of singlet oxygen (Q28484887) (← links)
- Human Polyomaviruses in Skin Diseases (Q30407393) (← links)
- Efficacy and side effects of natalizumab therapy in patients with multiple sclerosis (Q33573208) (← links)
- Molecular prevalence of JC virus in Tehran, Iran (Q33596398) (← links)
- Refractory T-Cell Anergy and Rapidly Fatal Progressive Multifocal Leukoencephalopathy After Prolonged CTLA4 Therapy (Q33806623) (← links)
- Agnoprotein of mammalian polyomaviruses (Q34283583) (← links)
- Characteristics of progressive multifocal leukoencephalopathy clarified through internet-assisted laboratory surveillance in Japan (Q34445672) (← links)
- Pur-Alpha Induces JCV Gene Expression and Viral Replication by Suppressing SRSF1 in Glial Cells (Q34529503) (← links)
- Outcome and survival of asymptomatic PML in natalizumab-treated MS patients (Q34562841) (← links)
- Novel polyomaviruses of nonhuman primates: genetic and serological predictors for the existence of multiple unknown polyomaviruses within the human population (Q34789283) (← links)
- Efficacy of recombinant human interleukin 7 in a patient with severe lymphopenia-related progressive multifocal leukoencephalopathy (Q34801893) (← links)
- Immunological Markers for PML Prediction in MS Patients Treated with Natalizumab (Q34818048) (← links)
- JC polyomavirus attachment, entry, and trafficking: unlocking the keys to a fatal infection. (Q35033782) (← links)
- Detection of human herpesviruses in the cerebrospinal fluid from patients diagnosed with or suspected of having progressive multifocal leukoencephalopathy (Q35065104) (← links)
- Heterogeneous imaging characteristics of JC virus granule cell neuronopathy (GCN): a case series and review of the literature (Q35314514) (← links)
- IFN-Gamma Inhibits JC Virus Replication in Glial Cells by Suppressing T-Antigen Expression (Q35659985) (← links)
- T helper cell- and CD40-dependent germline IgM prevents chronic virus-induced demyelinating disease (Q35708880) (← links)
- Incidence and risk factors for progressive multifocal leukoencephalopathy among patients with selected rheumatic diseases (Q35846542) (← links)
- CD8 T cells recruited early in mouse polyomavirus infection undergo exhaustion (Q35903231) (← links)
- JC virus promoter/enhancers contain TATA box-associated Spi-B-binding sites that support early viral gene expression in primary astrocytes (Q35960553) (← links)
- Dihydropyrimidinones and -thiones with improved activity against human polyomavirus family members (Q36131702) (← links)
- BK virus capsid antibodies are associated with protection against subsequent development of PML in HIV-infected patients (Q36202667) (← links)
- Human polyomavirus JC replication and non-coding control region analysis in multiple sclerosis patients under natalizumab treatment (Q36234246) (← links)
- Low frequencies of central memory CD4 T cells in progressive multifocal leukoencephalopathy (Q36242314) (← links)
- Polyomavirus JC urinary shedding in kidney and liver transplant recipients associated with reduced creatinine clearance. (Q36408288) (← links)
- Immunotherapies for Neurological Manifestations in the Context of Systemic Autoimmunity (Q36484399) (← links)
- Prevalence of Antibodies Against JC Virus in Patients With Refractory Crohn's Disease and Effects of Natalizumab Therapy. (Q36697972) (← links)
- Broadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathy (Q36764988) (← links)
- Concomitant granule cell neuronopathy in patients with natalizumab-associated PML (Q36783871) (← links)
- Immunological hallmarks of JC virus replication in multiple sclerosis patients on long-term natalizumab therapy (Q36827319) (← links)
- Diagnostic delay in progressive multifocal leukoencephalopathy (Q36891735) (← links)
- Recurrence of progressive multifocal leukoencephalopathy despite immune recovery in two HIV seropositive individuals. (Q37048819) (← links)
- A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomes (Q37135539) (← links)
- 5-HT2 receptors facilitate JC polyomavirus entry. (Q37336799) (← links)
- Human Polyomavirus JC monitoring and noncoding control region analysis in dynamic cohorts of individuals affected by immune-mediated diseases under treatment with biologics: an observational study (Q37361949) (← links)
- Inhibition of JCPyV infection mediated by targeted viral genome editing using CRISPR/Cas9 (Q37411994) (← links)
- Prophylactic antiepileptic treatment reduces seizure frequency in natalizumab-associated progressive multifocal leukoencephalopathy (Q37455953) (← links)
- Right Hemispheric Leukoencephalopathy as an Incidental Finding Following a Lightning Strike. (Q37523633) (← links)
- Progressive multifocal leukoencephalopathy in a 62-year-old immunocompetent woman (Q37663449) (← links)
- Immune surveillance and response to JC virus infection and PML. (Q37678580) (← links)